Simple Summary PSMA-PET is currently recommended to restage PCa and to guide
salvage treatments. We aim to evaluate the oncologic outcomes of patients with recurrent …

Purpose: The summary presented herein covers recommendations on salvage therapy for
recurrent prostate cancer intended to facilitate care decisions and aid clinicians in caring for …

Aim The optimal management for early recurrent prostate cancer following radical
prostatectomy (RP) in patients with negative prostate-specific membrane antigen positron …

Recognition of the importance of prostate-specific membrane antigen (PSMA) PET/CT in the
diagnosis of prostate cancer has steadily increased following the publication of extensive …

Simple Summary We looked at the long-term quality of life of patients treated with modern
radiotherapy for relapsed prostate cancer after initial surgery. By comparing the original …

Background and objectives Piflufolastat F 18 is a novel prostate-specific membrane antigen
(PSMA)-targeted positron emission tomography (PET) radiotracer that is superior to …

For prostate cancer, the role of elective nodal irradiation (ENI) for cN0 or pN0 patients has
been under discussion for years. Considering the recent publications of randomized …

Simple Summary We undertook an individual patient data meta-analysis of the overall
survival of 1216 patients with PSA-only recurrence of prostate cancer restaged with PSMA …

Simple Summary Prostate cancer often relapses after initial radical prostatectomy, and
salvage radiotherapy offers a second chance of cure for relapsed patients. Modern imaging …

Purpose or Objective—The aim of the study is to evaluate the efficacy and safety of SBRT on
detectable prostate bed recurrence in RT-naïve prostate cancer patients. Materials and …